Literature DB >> 20108571

[Diabetic edematous maculopathy associated with rosiglitazone treatment: report of a case].

V Nyssen1, F Hautenauven, J P Lekeu Hinostroza, A P Guagnini.   

Abstract

A 61-year-old woman is referred for bilateral diabetic macular edema. Her visual acuity is 20/70 in the right eye and 20/50 in the left eye. She presents a macular edema on both eyes. Her diabetes and her blood pressure are well controlled. We note that the decrease in visual acuity occured when the patient began taking rosiglitazone (Avandia) 4 mg per day. Three months after replacing rosiglitazone by gliclazide (Diamicron), the visual acuity of the patient improves to 20/40 in the right eye and 20/30 in the left eye.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20108571

Source DB:  PubMed          Journal:  Bull Soc Belge Ophtalmol        ISSN: 0081-0746


  3 in total

Review 1.  New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy.

Authors:  Mercy Saw; Vincent W Wong; I-Van Ho; Gerald Liew
Journal:  Eye (Lond)       Date:  2019-06-21       Impact factor: 3.775

Review 2.  Diabetic macular edema: correlations with available diabetes therapies--evidence across a qualitative review of published literature from MEDLINE and EMBASE.

Authors:  Domenico Merante; Francesca Menchini; Kenneth E Truitt; Francesco M Bandello
Journal:  Drug Saf       Date:  2010-08-01       Impact factor: 5.606

Review 3.  Systemic medical management of diabetic retinopathy.

Authors:  Gopal Lingam; Tien Yin Wong
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.